Improved injection safety after targeted interventions in the Syrian Arab Republic

Tropical Medicine and International Health

Volumn 12, Issue 3, 2007, Pages 422-430

  Mantel, Carsten ^a   Khamassi, Selma ^b   Baradei, Khaled ^c   Nasri, Haifa ^c   Mohsni, Ezzedine ^b   Duclos, Philippe ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Ministry of Health of the Syrian Arab Republic   (Syrian Arab Republic)

Author keywords

Focus Project; Hepatitis B Virus; Hepatitis C Virus; Human Immunodeficiency Virus; Immunization safety; Injection safety; Sharps waste; Syrian Arab Republic

Indexed keywords

HEALTH CARE; HEALTH MONITORING; HEALTH RISK; HEALTH WORKER; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; PATHOGEN; VACCINATION; WASTE DISPOSAL; WORLD HEALTH ORGANIZATION;

ARTICLE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INJECTION; MEDICAL INFORMATION; MEDICAL PRACTICE; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SAFETY; SYRIAN ARAB REPUBLIC; WASTE DISPOSAL; WASTE MANAGEMENT; WORLD HEALTH ORGANIZATION;

BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASES; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HOSPITALS; HUMANS; IMMUNIZATION; INFECTION CONTROL; INJECTIONS; MEDICAL WASTE DISPOSAL; NEEDLESTICK INJURIES; RISK FACTORS; SAFETY; SYRIA;

ASIA; EURASIA; MIDDLE EAST; SYRIAN ARAB REPUBLIC;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33847167542     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01802.x     Document Type: Article

References (35)

1. Bari A, Akhtar S, Rahbar MH & Luby SP (2001) Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Tropical Medicine and International Health 6, 732-738.
2. Dicko M, Oni A-QO, Ganivet S, Kone S, Pierre L & Jacquet B (2000) Safety of immunization injections in Africa: not simply a problem of logistics. Bulletin of the World Health Organization 78, 163-169.
3. Dziekan G, Chisholm DH, Johns B, Rovira J & Hutin YJF (2003) The cost effectiveness of policies for the safe and appropriate use of injection in health care settings. Bulletin of the World Health Organization 81, 277-285.
4. Hadiyono JEP, Suryawati S, Danu SS, Sunartono & Santoso B (1996) Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities. Social Science & Medicine 42, 1177-1183.
5. Hauri A, Armstrong G & Hutin Y (2004) The global burden of disease attributable to contaminated injections given in health care settings. International Journal of STD and AIDS 15, 7-16.
6. Hutin YJF & Chen RT (1999) Injection safety: a global challenge. Bulletin of the World Health Organization 77, 787-788.
7. Hutin YJF, Hauri AM & Armstrong AL (2003) Use of injections in health care settings world wide 2000: literature review and regional estimates. British Medical Journal 327, 1075.
8. Hutin YJF, Harpaz R, Drobeniuc J et al. (1999) Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. International Journal of Epidemiology 28, 782-786.
9. Kane A, Lloyd J, Zaffran M, Simonsen L & Kane M (1999) Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization 77, 801-807.
10. Kermode M, Holmes W, Biangtang L, Thomas MS & Gifford S (2005) Safer injections, fewer infections: injection safety in rural north India. Tropical Medicine and International Health 10, 423-432.
11. Kish L (1965) Survey Sampling. John Wiley & Sons, New York, p. 162.
12. Kotwal A (2005) Innovation, diffusion and safety of a medical technology: a review of the literature on injection practices. Social Science and Medicine 60, 1133-1147.
13. Kotwal A, Priya R, Thankur R, Gupta V, Kotwal J & Seth T (2004) Injection practices in a metropolis of North India: perceptions, determinants and issues of safety. Indian Journal of Medical Sciences 58, 334-344.
14. Lemeshow S, Hosmer DW, Klar D & Lwanga SK (1990) Adequacy of sample size in health studies. John Wiley & Sons, Chichester, pp. 59-60.
15. Logez S, Hutin Y, Somda P, Thuault J & Holloway K (2005) Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995-2000. BMC Public Health 5, 136.
16. Luby S, Hoodbhoy F, Jan A, Shah A & Hutin Y (2005) Long-term improvement in unsafe injection practices following community intervention. International Journal of Infectious Diseases 9, 52-59.
17. Miller M & Pisani E (1999) The cost of unsafe injections. Bulletin of the World Health Organization 77, 808-811.
18. Pasha O, Luby SP, Khan AJ, Shah SA, McCormick JB & Fisher-Hoch SP (1999) Household members of hepatitis C virus-infected people in Hafizabad, Pakistan: infection by injections from health care providers. Epidemiology Infection 123, 515-518.
19. Simonsen L, Kane A, Lloyd J, Zaffran M & Kane M (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bulletin of the World Health Organization 77, 789-800.
20. StataCorp (2002) Stata Statistical Software: Release 7.0. Stata Corporation, College Station, TX.
21. Vong S, Perz JF, Sok S et al. (2005) Rapid assessment of injection practices in Cambodia 2002. BioMed Central Public Health 5, 56.
22. Vos J, Gumodoka B, van Asten HA, Berege ZA, Dolmans WM & Borgdorff MW (1998) Improved injection practices after the introduction of treatment and sterility guidelines in Tanzania. Tropical Medicine and International Health 3, 291-296.
23. WHO (2000a) Aide-Memoire for a national strategy for the safe and appropriate use of injections. WHO Department of Blood Safety and Clinical Technology, Geneva.
24. WHO (2000b) Aide-Memoire for a national strategy for healthcare waste management. WHO, Geneva.
25. WHO (2001) A behaviour change strategy to promote the safe and appropriate use of injections. WHO, Geneva.
26. WHO (2002) World Health Report 2002: Reducing risks, promoting healthy life. WHO, Geneva, Switzerland.
27. WHO (2003) Procuring single-use injection equipment and safety boxes. WHO, Geneva (WHO/BCT/03.04).
28. WHO (2005) Global status of immunization safety: report based on the WHO/UNICEF Joint Reporting Form 2004 update. Weekly Epidemiological Record 80, 361-368.
29. WHO/BCT (2001) Best infection control practices for skinpiercings, intradermal, subcutaneous, and intramuscular needle injections. Geneva (WHO/BCT/DCT/01.02).
30. WHO/CDC (2003) Epi Info Software, Version 3.0. Epidemiology Programme Office, Centres for Disease Control and Prevention, Atlanta, USA; WHO Geneva, Switzerland.
31. WHO/EMRO (2001) Survey on the safety of injections in the Syrian Arab Republic, Cairo (EM/EPI/211/E/R/12.01/19).
32. WHO/EMRO (2004) Injection safety in immunization services: regional strategy and plan of action, draft.
33. WHO-UNICEF-UNFPA joint statement on the use of auto-disable syringes in immunization services (1999) Geneva (WHO/V&B/99.25).
34. WHO/V&B (2001) Tool for the assessment of injection safety, Geneva (WHO/V&B/01.30).
35. WHO/V&B (2002) "First do no harm" Introducing auto-disable syringes and ensuring injection safety in immunization systems of developing countries (WHO/V&B/02.26).